Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
034940
vs
K
KOSPI 200
Over the past 12 months, ChoA Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of -52% compared to KOSPI 200's +119% growth.
Stocks Performance
034940 vs KOSPI 200
Performance Gap
034940 vs KOSPI 200
Performance By Year
034940 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ChoA Pharmaceutical Co Ltd
Glance View
ChoA Pharmaceutical makes and sells pharmaceutical and health supplement products in South Korea. Its lineup includes over-the-counter medicines, herbal and digestive products, vitamins, probiotics, and other functional foods that people buy for everyday health needs. The company also appears in the supply chain as a manufacturer, so part of its business can come from making products for other brands as well as selling under its own names. Its main customers are pharmacies, clinics, distributors, and retail buyers who purchase health products for personal use. ChoA earns money by selling finished products through these channels, and in some cases by manufacturing goods for third parties that want a Korean production partner. That gives it two linked revenue streams: branded consumer sales and contract manufacturing. What makes the business easy to understand is that it sits between ingredient suppliers and the stores or distributors that reach end consumers. Instead of developing large prescription-drug franchises, ChoA focuses on familiar health products that are bought repeatedly and sold through pharmacy-style channels. That puts it in a part of the industry where product quality, brand trust, and stable distribution relationships matter more than blockbuster drugs.